On the fly News and insights, exclusive to thefly.com

BLCM

Bellicum Pharmaceuticals

$3.74 /

-2.16 (-36.61%)

, PRO

Pros Holdings

$26.16 /

-5.33 (-16.93%)

09:56
10/30/20
10/30
09:56
10/30/20
09:56

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Bellicum Pharmaceuticals (BLCM) downgraded to Equal Weight from Overweight at Wells Fargo and downgraded to Neutral from Buy at Ladenburg. 2. Pros Holdings (PRO) downgraded to Sector Weight from Overweight at KeyBanc and downgraded to Sector Perform from Outperform at RBC Capital. 3. Atlassian (TEAM) downgraded to Hold from Buy at Truist with analyst Joel Fishbein saying the company's Q1 results saw upside relative to estimates, but its cloud transition plan creates a "low visibility scenario" that may persist for "at least a year." 3. Blueprint downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Lebowitz saying while he still has a positive view on the company and its pipeline, he now thinks the share price "appropriately reflects recent achievements as well as upcoming catalysts." 5. Pixelworks (PXLW) downgraded to Hold from Buy at Lake Street with analyst Jaeson Schmidt saying while he doesn't think investors were expecting a snapback in Q4, he does think the company's "soft" guidance will still be disappointing. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

BLCM

Bellicum Pharmaceuticals

$3.74 /

-2.16 (-36.61%)

PRO

Pros Holdings

$26.16 /

-5.33 (-16.93%)

TEAM

Atlassian

$195.05 /

-15.95 (-7.56%)

BPMC

Blueprint Medicines

$102.03 /

-4.94 (-4.62%)

PXLW

Pixelworks

$2.08 /

-0.21 (-9.17%)

  • 11

    Nov

  • 17

    Nov

  • 17

    Nov

  • 23

    Nov

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.